Kaloian Koynov Selected Research

Kaloian Koynov Research Topics

15	Neoplasms (Cancer) 01/2022 - 09/2010
2	Papillomavirus Infections 12/2016 - 08/2014
2	Carcinoma (Carcinomatosis) 09/2013 - 09/2010
1	Tuberculosis (Tuberculoses) 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Cicatrix (Scar) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Inflammation (Inflammations) 10/2021
1	Communicable Diseases (Infectious Diseases) 02/2021
1	Respiratory Syncytial Virus Infections 12/2019
1	Rupture 06/2019
1	Fibrosarcoma 01/2018
1	Necrosis 07/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Obesity 08/2015
1	Adenocarcinoma 10/2012

8	PolymersIBA 12/2020 - 09/2010
3	VaccinesIBA 01/2022 - 02/2018
3	NanogelsIBA 01/2022 - 01/2021
3	Drug CarriersIBA 01/2018 - 09/2013
3	Proteins (Proteins, Gene)FDA Link 12/2016 - 08/2014
3	hydroxypropyl methacrylateIBA 11/2013 - 10/2012
2	AntigensIBA 01/2022 - 02/2021
2	riboflavin-binding proteinIBA 12/2020 - 01/2017
2	Riboflavin (Vitamin B2)FDA LinkGeneric 12/2020 - 01/2017
2	Folic Acid (Vitamin M)FDA LinkGeneric 10/2014 - 09/2010
1	pretomanidIBA 01/2023
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2022
1	polyethylene glycol polyethyleneimine nanogelIBA 01/2022
1	NanovaccinesIBA 01/2022
1	CollagenIBA 01/2022
1	Diphosphonates (Bisphosphonates)IBA 01/2022
1	OvalbuminIBA 01/2022
1	MicellesIBA 10/2021
1	IronIBA 10/2021
1	Peptides (Polypeptides)IBA 02/2021
1	Subunit VaccinesIBA 02/2021
1	EstersIBA 01/2021
1	Toll-Like Receptor 7IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 12/2019
1	HydrogelsIBA 06/2019
1	DuxonIBA 01/2018
1	histidine-rich proteinsIBA 01/2018
1	PolyethyleneimineIBA 07/2017
1	EndotoxinsIBA 07/2017
1	Silicon Dioxide (Silica)FDA LinkGeneric 07/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2017
1	CytokinesIBA 07/2017
1	Indicators and Reagents (Reagents)IBA 07/2017
1	AntibodiesIBA 01/2017
1	Viral DNAIBA 08/2014
1	dodecyl methacrylateIBA 09/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2012

5	Therapeutics 01/2023 - 02/2018
1	Intravenous Administration 01/2021
1	Immunotherapy 01/2021